ExecSalaries
Home · Compare

Mayukh Sukhatme vs Ms. Szyman

💰 How does your salary compare?
See how you rank against the world's top executives — free, instant, SEC-backed data
Try it →
Mayukh Sukhatme earned $246.3M (4471%) more than Ms. Szyman in their most recent fiscal years on record.
CompanyRoivant SciencesEdwards Lifesciences
TitlePresident and Chief Investment OfficerExecutive Officer
IndustryHealthcareHealthcare
Fiscal YearFY2024FY2024
Total Pay$251.9M$5.5M
Base Salary$550,000$490,769
Stock Awards$170.2M$4.2M
Bonus$81.1M$1,000
Data Source: Figures are sourced from each executive's most recent DEF 14A proxy filing on record with the SEC. See something wrong? Report it.
← Back to database · Mayukh Sukhatme's full profile · Ms. Szyman's full profile
ExecSalaries.com · Data sourced from SEC EDGAR DEF 14A proxy filings. · Home · About · Privacy Policy